Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 164 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Chronic Neuropathic Pain Clear all

Conditions: Neuropathic Pain, Spinal Cord Injury
Interventions: Neurofeedback; Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Chronic Pain Syndrome, Pain, Fibromyalgia, Low Back Pain, Neuropathic Pain, Neuropathy, Painful, Musculoskeletal Pain, Chronic Pain
Interventions: Self-administration of auricular acupuncture without prosthesis, Self-administration of auricular acupuncture with prosthesis; Procedure
Lead sponsor: Chillicothe VA Medical Center; Federal
Eligibility: 18 Years to 120 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Chillicothe, Ohio

Conditions: Chronic Osteoarthritis Pain, Chronic Low Back Pain
Interventions: PIPE-791, Placebo; Drug
Lead sponsor: Contineum Therapeutics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Phoenix, Arizona • Marietta, Georgia • Hartsdale, New York + 2 more

Conditions: Neuropathic Pain, Chronic Pain
Interventions: Active stimulation using low-frequency ultrasonic transducer, Sham stimulation using low-frequency ultrasonic transducer; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Diabetic Neuropathic Pain, Chronic Low Back Pain
Interventions: donepezil, duloxetine, donepezil 2.5 mg and duloxetine 30mg, placebo, gabapentin; Drug
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Winston-Salem, North Carolina • Cleveland, Ohio

Conditions: Chronic Pain, Chronic Lower Back Pain, Back Pain, Opioid Use, Opiate Dependence, Pain, Chronic, Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy
Interventions: Real TBS to the mPFC, Sham TBS to the mPFC, Real TBS to the MC, Sham TBS to the MC; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Neuropathic Pain, Complex Regional Pain Syndrome, Chronic Pain
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Diabetic Peripheral Neuropathic Pain
Interventions: RGH-896, pregabalin, placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 458 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2009
U.S. locations: 54
States / cities: Birmingham, Alabama • Mesa, Arizona • Tempe, Arizona + 51 more

Conditions: Chronic Pain, Hypertension, Implanted Stimulation Electrodes
Interventions: Diagnostic Tests; Diagnostic Test
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 30 Years to 89 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Fairway, Kansas • Kansas City, Kansas

Conditions: Chronic Pain, Musculoskeletal Pain, Fibromyalgia, Neuropathic Pain, Complex Regional Pain Syndromes, Abdominal Pain
Interventions: Empowered Relief for Youth; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Chronic Pain Syndrome
Interventions: MBSR treatment; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 381 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Chronic Low Back Pain, Lumbar Radiculopathy
Interventions: Low-dose naltrexone and acetaminophen combination, Placebo; Drug
Lead sponsor: Allodynic Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: North Miami, Florida

Conditions: Spinal Cord Injury, Chronic Pain
Interventions: Not listed
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Painful Diabetic Neuropathy
Interventions: GRT3938Y, Placebo; Drug
Lead sponsor: Grünenthal GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 553 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 61
States / cities: Fairhope, Alabama • Homewood, Alabama • Tucson, Arizona + 36 more

Conditions: Chemotherapy-induced Peripheral Neuropathy, Yoga, Chronic Pain, Neuropathic Pain
Interventions: Yoga; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cannabis, Low Back Pain, Neuropathic Pain
Interventions: Placebos, dronabinol, Vaporized Cannabis 3.7% THC/5.6% CBD; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 19 Years to 70 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Neuropathic Pain, Pain, Spinal Cord Injuries
Interventions: Venalafaxine hydrochloride; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Neuropathic Pain
Interventions: N-acetyl-l-cysteine; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Pediatric Chronic Neuropathic Pain
Interventions: Gabapentin, Oxcarbazepine, Placebo; Drug · Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Migraine, Cluster Headache, Trigeminal Neuralgia
Interventions: Ketorolac, Dexamethasone; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy, Neuropathy, Painful, Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy, Chronic Pain
Interventions: Yoga, Education control, Usual care; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 8
States / cities: Boston, Massachusetts • Basking Ridge, New Jersey • Middletown, New Jersey + 5 more

Conditions: Osteoarthritis, Knee, Diabetic Neuropathic Pain, Chronic Low-back Pain
Interventions: LY3016859 ISA, LY3556050 ISA, LY3526318 ISA, LY3857210 ISA, Placebo Oral, Placebo, LY4065967 ISA; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 62
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 52 more

Conditions: Chronic Pain Post-Procedural
Interventions: Senza HF10 Therapy; Device
Lead sponsor: Nevro Corp; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Greenfield, Wisconsin

Conditions: Chemotherapy-induced Peripheral Neuropathy
Interventions: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT; Device
Lead sponsor: Morgan State University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Baltimore, Maryland

Search by objective public record fields.

Brain Activity in People With Chronic Neuropathic Pain and Spinal Cord Injury

Veteran Ear Acupuncture Pilot Project

Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain

Noninvasive Modulation of Chronic Neuropathic Pain

Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy

Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain

IV Lidocaine Infusion for Neuropathic Pain

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain

Empowered Relief for Youth

Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients

Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)

Association Between Types of Pain and Motor Activities Physical Activity

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain

Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury

The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness Study

Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

HF10 Treatment of Chronic Knee Pain

Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation